Missouri
Requires Coverage of Comprehensive Biomarker Testing
No
Highlighted Disparity
Asian or Pacific Islander individuals in Missouri are least likely to be diagnosed early.
Lung Cancer Rates
New Cases:
- The rate of new lung cancer cases is 67.7 and significantly higher than the national rate of 53.6.
- Missouri ranks 44th among all states, placing it in the below average tier.
- Over the last five years, the rate of new cases improved by 16%.
5-Year Survival Rate:
- The percent of people alive five years after being diagnosed with lung cancer (the survival rate) in Missouri is 26.5%, which is significantly lower than the national rate of 28.4%.
- It ranks 30th among the 47 states with survival data, placing it in the below average tier.
- Over the last five years, the survival rate in Missouri improved by 28%.
Early Diagnosis:
- 27.9% of cases are caught at an early stage, which is not significantly different than the national rate of 27.4%.
- It ranks 22nd among the 47 states with data on diagnosis at an early stage, placing it in the average tier.
- Over the last five years, the early diagnosis rate in Missouri improved by 16%.
Lung Cancer Treatment
Biomarker Coverage:
- Missouri has yet to require any insurance coverage of comprehensive biomarker testing, including for lung cancer, as of September 2024.
Surgical Treatment:
- Missouri ranked 33rd (out of the 47 states with available data) with 17.8% of cases undergoing surgery as part of the first course of treatment.
- This is significantly lower than the national rate of 20.7% and puts Missouri in the below average tier.
- Over the last five years, the percent of cases undergoing surgery in Missouri did not change significantly.
Lack of Treatment:
- Missouri ranked 5th (out of the 47 states with available data) with 16.2% of cases not receiving any treatment.
- This is significantly lower than the national rate of 20.9% and puts Missouri in the top tier.
- Over the last five years, the percent of cases receiving no treatment in Missouri increased by 12%.
Screening
Screening for High Risk:
- In Missouri, 16.5% of those at high risk were screened, which was not significantly different than the national rate of 16.0%.
- It ranks 27th among all states, placing it in the average tier.
Prevention
Tobacco Use:
- The smoking rate in Missouri is 16.8% and significantly higher than the national rate of 12.9%.
- It ranks 45th among all states, placing it in the below average tier.
Radon:
- In Missouri, 31.0% of radon tests results were at or above the action level recommended by EPA.
- It ranks 32nd among all states, placing it in the below average tier.
Racial & Ethnic Disparities
Black individuals:
- The rate of new lung cancer cases is 72.0 per 100,000 population among Black individuals in Missouri, significantly higher than the rate of 55.1 among Black individuals nationally, and not significantly different than the rate of 68.5 among white individuals in Missouri.
- The five-year survival rate is 26.3% among Black individuals in Missouri, not significantly different than the rate of 25.5% among Black individuals nationally, and not significantly different than the rate of 26.5% among white individuals in Missouri.
- 27.6% of lung cancer cases are diagnosed at an early stage among Black individuals in Missouri, significantly higher than the rate of 24.1% among Black individuals nationally, and not significantly different than the rate of 28.1% among white individuals in Missouri.
- 13.8% of Black individuals with lung cancer in Missouri underwent surgery, significantly lower than the rate of 17.0% among Black individuals nationally, and significantly lower than the rate of 18.1% among white individuals in Missouri.
- 18.3% of Black individuals with lung cancer in Missouri did not receive any treatment, significantly lower than the rate of 22.7% among Black individuals nationally, and significantly higher than the rate of 16.1% among white individuals in Missouri.
Latino individuals:
- The rate of new lung cancer cases is 29.7 per 100,000 population among Latino individuals in Missouri, not significantly different than the rate of 28.1 among Latino individuals nationally, and significantly lower than the rate of 68.5 among white individuals in Missouri.
- State-level survival rates are not available for Latino individuals at this time. Nationally, the five-year survival rate among Latino individuals is 22.7%, not significantly different than the rate of 25.0% among white individuals.
- 24.8% of lung cancer cases are diagnosed at an early stage among Latino individuals in Missouri, not significantly different than the rate of 23.5% among Latino individuals nationally, and not significantly different than the rate of 28.1% among white individuals in Missouri.
- 23.3% of Latino individuals with lung cancer in Missouri underwent surgery, not significantly different than the rate of 21.3% among Latino individuals nationally, and significantly higher than the rate of 18.1% among white individuals in Missouri.
- 12.9% of Latino individuals with lung cancer in Missouri did not receive any treatment, significantly lower than the rate of 26.3% among Latino individuals nationally, and not significantly different than the rate of 16.1% among white individuals in Missouri.
Asian Americans or Pacific Islanders:
- The rate of new lung cancer cases is 38.2 per 100,000 population among Asian or Pacific Islanders individuals in Missouri, not significantly different than the rate of 32.5 among Asian or Pacific Islanders individuals nationally, and significantly lower than the rate of 68.5 among white individuals in Missouri.
- State-level survival rates are not available for Asian or Pacific Islander individuals at this time. Nationally, the five-year survival rate among Asian or Pacific Islander individuals is 28.6% and significantly higher than the rate of 25.0% among white individuals.
- 20.7% of lung cancer cases are diagnosed at an early stage among Asian or Pacific Islander individuals in Missouri, not significantly different than the rate of 23.4% among Asian or Pacific Islander individuals nationally, and significantly lower than the rate of 28.1% among white individuals in Missouri.
- 22.1% of Asian or Pacific Islander individuals with lung cancer in Missouri underwent surgery, not significantly different than the rate of 24.7% among Asian or Pacific Islander individuals nationally, and not significantly different than the rate of 18.1% among white individuals in Missouri.
- 12.2% of Asian or Pacific Islander individuals with lung cancer in Missouri did not receive any treatment, significantly lower than the rate of 20.1% among Asian or Pacific Islander individuals nationally, and not significantly different than the rate of 16.1% among white individuals in Missouri. .
Indigenous Peoples:
- The rate of new lung cancer cases is 26.6 per 100,000 population among Indigenous Peoples (American Indians/Alaska Natives) in Missouri, significantly lower than the rate of 39.9 among Indigenous Peoples nationally, and significantly lower than the rate of 68.5 among white individuals in Missouri.
- State-level survival rates are not available for Indigenous Peoples at this time. Nationally, the five-year survival rate among Indigenous Peoples is 22.3% and not significantly different than the rate of 25.0% among white individuals.
- Other lung cancer rates are not available for Indigenous Peoples (American Indians/Alaska Natives) in Missouri due to too few cases over the time period to allow for accurate analysis.
Summary
Despite the early diagnosis rate in Missouri falling into the average tier, the state still has a lot of work to do to make sure that more of those at high risk for lung cancer are screened.
Missouri has yet to require any insurance coverage of comprehensive biomarker testing, which can help determine what treatment options would be best for individuals with lung cancer and other diseases.
Missouri falls into the top tier for percent of patients receiving no treatment. Some patients do refuse treatment, but issues such as fatalism and stigma can prevent eligible patients from accessing treatment that may save or extend their lives. All patients should work with their doctors to establish a treatment plan and goals.
Page last updated: November 12, 2024